|
|
Prepublished online as a Blood First Edition Paper on June 5, 2003; DOI 10.1182/blood-2002-12-3817.
 Previous Article | Table of Contents | Next Article 
Blood, 1 October 2003, Vol. 102, No. 7, pp. 2321-2333
REVIEW ARTICLES
Leukemia in twins: lessons in natural history
Mel F. Greaves,
Ana Teresa Maia,
Joseph L. Wiemels, and
Anthony M. Ford
From the Leukaemia Research Fund Centre, Institute of Cancer Research, London, United Kingdom.
Identical infant twins with concordant leukemia were first described in 1882, and since that time many such pairs of infants and older children have been described. It has long been recognized that this situation offers a unique opportunity to identify aspects of the developmental timing, natural history, and molecular genetics of pediatric leukemia in general. We reviewed both the older literature and more recent molecular biologic studies that have uncovered the basis of concordance of leukemia. Molecular markers of clonality, including unique, genomic fusion gene sequences, have provided unequivocal evidence that twin pairs of leukemia have a common clonal origin. The only plausible basis for this, first suggested more than 40 years ago, is that following initiation of leukemia in one twin fetus, clonal progeny spread to the co-twin via vascular anastomoses within a single, monochorionic placenta. This explanation has been endorsed by the identification of clonotypic gene fusion sequences in archived neonatal blood spots of individuals who subsequently developed leukemia. These analyses of twin leukemias have thrown considerable light on the natural history of disease. They reveal a frequent prenatal origin and an early or initiating role for chromosome translocations. Further, they provide evidence for a variable and often protracted latency and the need, in childhood acute lymphoblastic leukemia (ALL)/acute myeloblastic leukemia (AML), for further postnatal exposures and/or genetic events to produce clinical disease. We argue that these insights provide a very useful framework for attempts to understand etiologic mechanisms. (Blood. 2003;102:2321-2333)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. K. Chuk, E. McIntyre, D. Small, and P. Brown
Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin
Blood,
June 25, 2009;
113(26):
6691 - 6694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Horton, V. Walf-Vorderwulbecke, S. J. Chatters, N. J. Sebire, J. de Boer, and O. Williams
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities
Blood,
May 14, 2009;
113(20):
4922 - 4929.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Harper and P. D. Aplan
Chromosomal Rearrangements Leading to MLL Gene Fusions: Clinical and Biological Aspects
Cancer Res.,
December 15, 2008;
68(24):
10024 - 10027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Chokkalingam and P. A. Buffler
Genetic susceptibility to childhood leukaemia
Radiat Prot Dosimetry,
December 1, 2008;
132(2):
119 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Crump, B. Coiffier, E. D. Jacobsen, L. Sun, J. L. Ricker, H. Xie, S. R. Frankel, S. S. Randolph, and B. D. Cheson
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
Ann. Onc.,
May 1, 2008;
19(5):
964 - 969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hong, R. Gupta, P. Ancliff, A. Atzberger, J. Brown, S. Soneji, J. Green, S. Colman, W. Piacibello, V. Buckle, et al.
Initiating and Cancer-Propagating Cells in TEL-AML1-Associated Childhood Leukemia
Science,
January 18, 2008;
319(5861):
336 - 339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Eguchi-Ishimae, M. Eguchi, H. Kempski, and M. Greaves
NOTCH1 mutation can be an early, prenatal genetic event in T-ALL
Blood,
January 1, 2008;
111(1):
376 - 378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rossi, K. Szuhai, M. Ijszenga, H. J. Tanke, L. Zanatta, R. Sciot, C. D.M. Fletcher, A. P. Dei Tos, and P. C.W. Hogendoorn
EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma
Clin. Cancer Res.,
December 15, 2007;
13(24):
7322 - 7328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Milne, C. L. Laurvick, E. Blair, C. Bower, and N. de Klerk
Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight
Am. J. Epidemiol.,
July 15, 2007;
166(2):
151 - 159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E Roman, J Simpson, P Ansell, S Kinsey, C. Mitchell, P. McKinney, J. Birch, M Greaves, T Eden, and on behalf of the United Kingdom Childhood Cancer S
Childhood Acute Lymphoblastic Leukemia and Infections in the First Year of Life: A Report from the United Kingdom Childhood Cancer Study
Am. J. Epidemiol.,
March 1, 2007;
165(5):
496 - 504.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Maule, F. Merletti, G. Pastore, C. Magnani, and L. Richiardi
Effects of Maternal Age and Cohort of Birth on Incidence Time Trends of Childhood Acute Lymphoblastic Leukemia
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2007;
16(2):
347 - 351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Spector, S. M. Davies, L. L. Robison, J. M. Hilden, M. Roesler, and J. A. Ross
Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2007;
16(1):
128 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Spector and J. A. Ross
Infant Leukemia: Finding the Needle in the Haystack
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2006;
15(12):
2331 - 2331.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Greaves and C. W. E. So
Alert and sniffy-nosed about Mll-AF4?
Blood,
July 15, 2006;
108(2):
416 - 417.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Di Croce
Chromatin modifying activity of leukaemia associated fusion proteins
Hum. Mol. Genet.,
April 15, 2005;
14(suppl_1):
R77 - R84.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Spector, Y. Xie, L. L. Robison, N. A. Heerema, J. M. Hilden, B. Lange, C. A. Felix, S. M. Davies, J. Slavin, J. D. Potter, et al.
Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2005;
14(3):
651 - 655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Bocskay, D. Tang, M. A. Orjuela, X. Liu, D. P. Warburton, and F. P. Perera
Chromosomal Aberrations in Cord Blood Are Associated with Prenatal Exposure to Carcinogenic Polycyclic Aromatic Hydrocarbons
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2005;
14(2):
506 - 511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Smith, J. D. Cavenagh, T. A. Lister, and J. Fitzgibbon
Mutation of CEBPA in Familial Acute Myeloid Leukemia
N. Engl. J. Med.,
December 2, 2004;
351(23):
2403 - 2407.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tsuzuki, M. Seto, M. Greaves, and T. Enver
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice
PNAS,
June 1, 2004;
101(22):
8443 - 8448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-H. Pui, M. V. Relling, and J. R. Downing
Acute Lymphoblastic Leukemia
N. Engl. J. Med.,
April 8, 2004;
350(15):
1535 - 1548.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shimada, G. Xu, T. Toki, H. Kimura, Y. Hayashi, and E. Ito
Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome
Blood,
January 1, 2004;
103(1):
366 - 366.
[Full Text]
[PDF]
|
|
|
|
|
